Plasma antioxidant enzymes and clastogenic factors as possible biomarkers of colorectal cancer risk

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 714, Issue 1-2, 2011, Pages 88-92

  Maffei, Francesca ^a   Angeloni, Cristina ^a   Malaguti, Marco ^a   Moraga, Juan Manuel Zolezzi ^a   Pasqui, Francesca ^a   Poli, Carolina ^a   Colecchia, Antonio ^a   Festi, Davide ^a   Hrelia, Patrizia ^a   Hrelia, Silvana ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Biomarkers; Colorectal cancer; Genetic damage; Oxidative stress

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; CATALASE; CLASTOGEN; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER PREVENTION; CANCER RISK; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FACTORIAL ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MICRONUCLEUS TEST; OCCULT BLOOD; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL;

AGED; CATALASE; COLORECTAL NEOPLASMS; FEMALE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MICRONUCLEUS TESTS; MIDDLE AGED; MUTAGENS; OCCULT BLOOD; OXIDATIVE STRESS; RISK FACTORS; SUPEROXIDE DISMUTASE; TUMOR MARKERS, BIOLOGICAL;

EID: 80051815644     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2011.06.016     Document Type: Article

References (45)

1. Levin B., Lieberman D.A., McFarland B., Andrews K.S., Brooks D., Bond J., Dash C., Giardiello F.M., Glick S., Johnson D., Johnson C.D., Levin T.R., Pickhardt P.J., Rex D.K., Smith R.A., Thorson A., Winawer S.J. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US multi-society task force on colorectal cancer, and the American College of Radiology. Gastroenterology 2008, 134:1570-1595.
2. Cappell M.S. Pathophysiology, clinical presentation, and management of colon cancer. Gastroenterol. Clin. North Am. 2008, 37:1-24.
3. Grady W.M., Carethers J.M. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 2008, 135:1079-1099.
4. Blau S., Rubinstein A., Bass P., Singaram C., Kohen R. Differences in the reducing power along the rat GI tract: lower antioxidant capacity of the colon. Mol. Cell. Biochem. 1999, 194:185-191.
5. Sun Y. Free radicals, antioxidant enzymes, and carcinogenesis. Free Radical Biol. Med. 1990, 8:583-599.
6. Datta K., Sinha S., Chattopadhyay P. Reactive oxygen species in health and disease. Natl. Med. J. Ind. 2000, 13:304-310.
7. Mates J.M., Perez-Gomez C., Nunez de Castro I. Antioxidant enzymes and human diseases. Clin. Biochem. 1999, 32:595-603.
8. Ray G., Husain S.A. Oxidants, antioxidants and carcinogenesis. Ind. J. Exp. Biol. 2002, 40:1213-1232.
9. Zhou J.F., Xu G.B., Fang W.J. Relationship between acute organophosphorus pesticide poisoning and damages induced by free radicals. Biomed. Environ. Sci. 2002, 15:177-186.
10. Ozdemirler Erata G., Kanbagli O., Durlanik O., Bulut T., Toker G., Uysal M. Induced oxidative stress and decreased expression of inducible heat shock protein 70 (ihsp 70) in patients with colorectal adenocarcinomas. Jpn. J. Clin. Oncol. 2005, 35:74-78.
11. Skrzydlewska E., Sulkowski S., Koda M., Zalewski B., Kanczuga-Koda L., Sulkowska M. Lipid peroxidation and antioxidant status in colorectal cancer. World J. Gastroenterol. 2005, 11:403-406.
12. Devasena T., VenugopalMenon P. Fenugreek seeds modulate 1,2-dimethylhydrazine-induced hepatic oxidative stress during colon carcinogenesis. Ital. J. Biochem. 2007, 56:28-34.
13. Rainis T., Maor I., Lanir A., Shnizer S., Lavy A. Enhanced oxidative stress and leucocyte activation in neoplastic tissues of the colon. Dig. Dis. Sci. 2007, 52:526-530.
14. Lindholm C., Acheva A., Salomaa S. Clastogenic plasma factors: a short overview. Radiat. Environ. Biophys. 2010, 49:133-138.
15. Emerit M., Quastel J., Goldsmith L., Merkin A., Levy L., Cernjavski A., Alaoui-Youssefi A., Pogossian E., Riklis Clastogenic factors in the plasma of children exposed at Chernobyl. Mutat. Res. 1997, 373:47-54.
16. Ballardin M., Gemignani F., Bodei L., Mariani G., Ferdeghini M., Rossi A.M., Migliore L., Barale R. Formation of micronuclei and of clastogenic factor(s) in patients receiving therapeutic doses of iodine-131. Mutat. Res. 2002, 514:77-85.
17. Ballardin M., Barsacchi R., Bodei L., Caraccio N., Cristofani R., Di Martino F., Ferdeghini M., Kusmic C., Madeddu G., Monzani F., Rossi A.M., Sbrana I., Spanu A., Traino C., Barale R. Oxidative and genotoxic damage after radio-iodine therapy of Graves' hyperthyroidism. Int. J. Radiat. Biol. 2004, 80:209-216.
18. World Medical Association. Declaration of Helsinki: ethical principles for medial research involving human subjects. Available from: http://www.wma.net/policy/b3.htm.
19. Smith I.K., Vierheller T.L., Thorne C.A. Assay of glutathione reductase in crude tissue homogenates using 5,5'-dithiobis(2-nitrobenzoic acid). Anal. Biochem. 1988, 175:408-413.
20. Johansson L.H., Borg L.A. A spectrophotometric method for determination of catalase activity in small tissue samples. Anal. Biochem. 1988, 174:331-336.
21. Peskin A.V., Winterbourn C.C. A microtiter plate assay for superoxide dismutase using a water-soluble tetrazolium salt (WST-1). Clin. Chim. Acta 2000, 293:157-166.
22. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249:7130-7139.
23. Fenech M., Morley A.A. Measurement of micronuclei in lymphocytes. Mutat. Res. 1985, 147:29-36.
24. Maffei F., Fimognari C., Castelli E., Stefanini G.F., Cantelli Forti G., Hrelia P. Increased cytogenetic damage detected by FISH analysis on micronuclei in peripheral lymphocytes from alcoholics. Mutagenesis 2000, 15:517-523.
25. Maffei F., Angelini S., Cantelli Forti G.C., Lodi V., Violante F.S., Mattioli S., Hrelia P. Micronuclei frequencies in hospital workers occupationally exposed to low levels of ionizing radiation: influence of smoking status and other factors. Mutagenesis 2002, 17:405-409.
26. Fenech M. The cytokinesis-block micronucleus technique: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat. Res. 1993, 285:35-44.
27. Wild N.,H.A., Rollinger W., Krause F., Dilba P., Tacke M., Karl J. A combination of serum markers for the early detection of colorectal cancer. Clin. Cancer Res. 2010, 16:6111-6121.
28. Kekec Y., Paydas S., Tuli A., Zorludemir S., Sakman G., Seydaoglu G. Antioxidant enzyme levels in cases with gastrointesinal cancer. Eur. J. Int. Med. 2009, 20:403-406.
29. Szatrowski T.P., Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 1991, 51:794-798.
30. Zuo X.L., Chen J.M., Zhou X., Li X.Z., Mei G.Y. Levels of selenium, zinc, copper, and antioxidant enzyme activity in patients with leukemia. Biol. Trace Elem. Res. 2006, 114:41-53. 2006.
31. Rajneesh C.P., Manimaran A., Sasikala K.R., Adaikappan P. Lipid peroxidation and antioxidant status in patients with breast cancer. Singapore Med. J. 2008, 49:640-643.
32. Badid N., Ahmed F.Z., Merzouk H., Belbraouet S., Mokhtari N., Merzouk S.A., Benhabib R., Hamzaoui D., Narce M. Oxidant/antioxidant status, lipids and hormonal profile in overweight women with breast cancer. Pathol. Oncol. Res. 2009, 16:159-167.
33. Valko M., Rhodes C.J., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 2006, 160:1-40.
34. Davies K.J., Delsignore M.E., Lin S.W. Protein damage and degradation by oxygen radicals. II. Modification of amino acids. J. Biol. Chem. 1987, 262:9902-9907.
35. Du J., Gebicki J.M. DNA degradation and protein peroxidation in cells exposed to hydroxyl free radicals. Redox Rep. 2002, 7:329-331.
36. Mayo J.C., Tan D.X., Sainz R.M., Lopez-Burillo S., Reiter R.J. Oxidative damage to catalase induced by peroxyl radicals: functional protection by melatonin and other antioxidants. Free Radical Res. 2003, 37:543-553.
37. Tan K.L., Chelvanayagam G., Parker M.W., Board P.G. Mutagenesis of the active site of the human theta-class glutathione transferase GSTT2-2: catalysis with different substrates involves different residues. Biochem. J. 1996, 319(Pt 1):315-321.
38. Hayes J.D., Pulford D.J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 1995, 30:445-600.
39. Rebbeck T.R. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. 1997, 6:733-743.
40. Strange R.C., Matharoo B., Faulder G.C., Jones P., Cotton W., Elder J.B., Deakin M. The human glutathione S-transferases: a case-control study of the incidence of the GST1 0 phenotype in patients with adenocarcinoma. Carcinogenesis 1991, 12:25-28.
41. Cotton S.C., Sharp L., Little J., Brockton N. Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am. J. Epidemiol. 2000, 151:7-32.
42. Chang D., Wang F., Zhao Y.S., Pan H.Z. Evaluation of oxidative stress in colorectal cancer patients. Biomed. Environ. Sci. 2008, 21:286-289.
43. Scibior D., Skrzycki M., Podsiad M., Czeczot H. Glutathione level and glutathione-dependent enzyme activities in blood serum of patients with gastrointestinal tract tumors. Clin. Biochem. 2008, 41:852-858.
44. Fenech M., Kirsch-Volders M., Natarajan A.T., Surrales J., Crott J.W., Parry J., Norppa H., Eastmond D.A., Tucker J.D., Thomas P. Molecular mechanisms of micronuclei, nucleopòasmic bridge and nuclear bud formation in mammalian and human cells. Muatgenesis 2011, 26:125-132.
45. Emerit I., Serejo F., de Moura M.C. Clastogenic factors in the plasma of patients with hepatitis C: their possiple role at the origin of hepatocarcinoma. Cancer Gen. Cytogen. 2007, 179:31-35.